Malignant glioma grade 3 and 4: How relevant is timing of radiotherapy?

Clinical Neurology and Neurosurgery

Volumn 114, Issue 6, 2012, Pages 617-621

  Wehming, Friederike M ^a   Wiese, Bettina ^b   Nakamura, Makoto ^a   Bremer, Michael ^a   Karstens, Johann H ^a   Meyer, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Henriettenstiftung   (Germany)

Author keywords

Brain tumor; Malignant glioma; Overall treatment time; Radiotherapy; Treatment delay

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PROGRESSION FREE SURVIVAL; TIME; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BRAIN NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROSURGICAL PROCEDURES; OLIGODENDROGLIOMA; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862010453     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2011.12.024     Document Type: Article

References (28)

1. S.H. Yang, M.K. Kim, and T.K. Lee Temozolomide chemotherapy in patients with recurrent malignant gliomas J Korean Med Sci 21 2006 739 744
2. K.L. Chaichana, S.L. Parker, A. Olivi, and A. Quin-ones-Hinojosa Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas J. Neurosurg 111 2009 282 292
3. B. Kim, E. Soisson, C. Duma, P. Chen, R. Hafer, and C. Cox Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy Clin Neurol Neurosurg 113 2011 509 512
4. C. Nieder, N. Andratschke, N. Wiedenmann, R. Busch, A.L. Grosu, and M. Molls Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 180 2004 401 407
5. M. Kocher, S. Kunze, H.T. Eich, R. Semrau, and R.P. Müller Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma Strahlenther Onkol 181 2005 157 163
6. A.A. Argyriou, A. Antonacopoulou, G. Iconomou, and H.P. Kalofonos Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies Crit Rev Oncol Hematol 69 2009 199 210
7. A. Natalwala, V. Bharkhada, G. Noel, and G. Cruickshank Comparison of time taken from initial presentation to histological diagnosis of glioblastoma multiforme (GBM) in Birmingham, United Kingdom and Strasbourg, France Clin Neurol Neurosurg 113 2011 358 361
8. J. Lutterbach, W. Sauerbrei, and R. Guttenberger Multivariate analysis of prognostic factors in patients with glioblastoma Strahlenther Onkol 179 2003 8 15
9. S. Combs, M. Nagy, and L. Edler Comparative evaluation of radiotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors Radiother Oncol 88 2008 177 182
10. M. Nagy, D. Schulz-Ertner, and M. Bischof Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas Tumori 95 2009 317 324
11. J.R. Simpson, J. Horton, and C. Scott Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials Int J Radiat Oncol Biol Phys 26 1993 239 244
12. T. Homma, T. Fukushima, and S. Vaccarella Correlation among pathology, genotype, and patient outcomes in glioblastoma J Neuropathol Exp Neurol 65 2006 846 854
13. W.J. Curran, C.B. Scott, and J. Horton Rucursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials J Natl Cancer Inst 85 1993 702 710
14. F.W. Kreth, A. Berlis, and V. Spiropoulou The role of tumor resection in the treatment of glioblastoma multiforme in adults Cancer 86 1999 2117 2123
15. A. Tsitlakidis, N. Foroglou, C.A. Venetis, I. Patsalas, A. Hatzisotiriou, and P. Selviaridis Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis J Neurosurg 112 2010 1020 1032
16. A. Muacevic, and F.W. Kreth Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme J Neurol 250 2003 561 568
17. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
18. W. Wick, C. Hartmann, and C. Engel NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide J Clin Oncol 27 2009 5874 5880
19. M.B. Barton, G. Morgan, R. Smee, K.W. Tiver, C. Hamilton, and V. Gebski Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol 44 1997 137 141
20. M.A. Richards, A.M. Westcombe, S.B. Love, P. Littlejohns, and A.J. Ramirez Influence of delay on survival in patients with breast cancer: a systematic review Lancet 353 1999 1119 1126
21. A. Taghian, J. Ramsay, and J. Allalunis-Turner Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme Int J Radiat Oncol Biol Phys 25 1993 243 249
22. V. Do, V. Gebski, and M. Barton The effect of waiting for grade III/IV gliomas Radiother Oncol 57 2000 131 136
23. C. Irwin, M. Hunn, G. Purdie, and D. Hamilton Delay in radiotherapy shortens survival in patients with high grade glioma J Neurooncol 85 2007 339 343
24. M.C. Hulshof, R.W. Koot, E.C. Schimmel, F. Dekker, D.A. Bosch, and D. González González Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution Strahlenther Onkol 177 2001 283 290
25. J. Lutterbach, P. Weigel, R. Guttenberger, and W. Hinkelbein Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme Radiother Oncol 53 1999 49 52
26. D.T. Blumenthal, M. Won, and M.P. Mehta Short delay in initation radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database J Clin Oncol 27 2009 733 739
27. R. Lai, D.L. Hershman, T. Doan, and A.I. Neugut The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme Neuro Oncol 12 2010 190 198
28. Y.R. Lawrence, D.T. Blumenthal, D. Matceyevsky, A.A. Kanner, F. Bokstein, and B.W. Corn Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? J Neurooncol 105 2011 1 7